With a revenue increase of 83.92% in the fourth quarter 2025, year on year to cumulative value of $158 million, Day One Biopharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 888,663. The productivity of Day One Biopharmaceuticals Inc 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 73 other companies have achieved higher revenue per employee. While Day One Biopharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 308 to 723. Day One Biopharmaceuticals Inc has 178 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

DAWN Revenue per Employee	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter
Y / Y Revenue Change	83.92 %	-57.56 %	313.92 %	-	-
Sales per Employee (TTM) $	888,663	750,966	1,054,146	909,674	736,860
DAWN's Total Ranking	# 723	# 308	# 181	# 122	# 0
Seq. Revenue Change	34.99 %	17.36 %	10.23 %	5.32 %	-68.85 %

DAWN Company Profile >> Back to DAWN Efficiency Comparisons >> Compare DAWN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 39
Healthcare Sector	# 74
Overall Market	# 723

Revenue per Employee Statistics
High	Average	Low
$ 1,036,674	$ 885,931	$ 738,519
(Jun 30 2025)		(Sep 30 2025)

Financial Statements
Day One Biopharmaceuticals Inc 's Revenue MRQ	$ 54 Millions	Visit DAWN's Income Statement
Day One Biopharmaceuticals Inc 's Revenues TTM	$ 158 Millions	Visit DAWN's aggregate revenue growth
What are DAWN's Sales?		Visit DAWN's Sales by Segment

Other Ratios
Day One Biopharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
DAWN's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for DAWN's Competitors
Revenue per Employee for DAWN's Suppliers
Revenue per Employee for DAWN's Customers

You may also want to know
DAWN's Sales Growth Rates	DAWN's Pe Price to earnings ratio	DAWN's Receivables Turnover Ratio	DAWN's Stock Quote
DAWN's Net Income Growth Rates	DAWN's Ps Price to Sales ratio	DAWN's Sales per Employee	DAWN's Asset Turnover Ratio
DAWN's Net Margin	DAWN's Pb Price to Book ratio	DAWN's Financial Strength Ratios	DAWN's Dividend Payout Ratio

Date modified: 2026-08-29T01:18:37+00:00

Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Dec 31 2025	Number of Employees Dec 31 2025
Tg Therapeutics Inc	1,544,578.95	$ 616.287 Million	399
Arrowhead Pharmaceuticals Inc	1,534,431.79	$ 1,090.981 Million	711
Progyny Inc	1,505,238.32	$ 1,288.484 Million	856
Novavax inc	1,499,971.96	$ 1,123.479 Million	749
Xenetic Biosciences Inc	1,488,205.50	$ 2.976 Million	2
Alnylam Pharmaceuticals Inc	1,485,574.80	$ 3,713.937 Million	2,500
Bristol myers Squibb Company	1,482,892.31	$ 48,194.000 Million	32,500
Jazz Pharmaceuticals Plc	1,476,673.36	$ 4,267.586 Million	2,890
Nuvation Bio Inc	1,439,139.53	$ 61.883 Million	43
Neurocrine Biosciences Inc	1,430,250.00	$ 2,860.500 Million	2,000
Agenus Inc	1,409,827.16	$ 114.196 Million	81
Mirum Pharmaceuticals Inc	1,401,376.34	$ 521.312 Million	372
Valneva Se	1,397,272.00	$ 195.618 Million	140
Esperion Therapeutics Inc	1,371,207.48	$ 403.135 Million	294
Apellis Pharmaceuticals Inc	1,358,297.70	$ 1,003.782 Million	739
Acadia Pharmaceuticals Inc	1,342,738.10	$ 1,071.505 Million	798
Krystal Biotech Inc	1,319,084.75	$ 389.130 Million	295
Biogen Inc	1,318,746.67	$ 9,890.600 Million	7,500
Eli Lilly And Company	1,303,580.00	$ 65,179.000 Million	50,000
Lantheus Holdings Inc	1,291,661.36	$ 1,540.952 Million	1,193
Puma Biotechnology Inc	1,275,815.64	$ 228.371 Million	179
Fennec Pharmaceuticals Inc	1,275,485.71	$ 44.642 Million	35
Indivior Pharmaceuticals Inc	1,240,000.00	$ 1,240.000 Million	1,000
Amicus Therapeutics inc	1,238,410.96	$ 632.828 Million	511
Tarsus Pharmaceuticals Inc	1,219,891.89	$ 451.360 Million	370
Akebia Therapeutics Inc	1,217,505.15	$ 236.196 Million	194
Heron Therapeutics Inc	1,207,476.56	$ 154.557 Million	128
Theravance Biopharma inc	1,194,044.44	$ 107.464 Million	90
Scynexis Inc	1,144,500.00	$ 20.601 Million	18
Cytomx Therapeutics Inc	1,104,362.32	$ 76.201 Million	69

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.